Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 16, 2017 - Issue 3
Submit an article Journal homepage
738
Views
13
CrossRef citations to date
0
Altmetric
Review

The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis

J. BraunRheumazentrum Ruhrgebiet, Herne, GermanyCorrespondence[email protected]
View further author information
&
J. KayDivision of Rheumatology, Department of Medicine, UMass Memorial Medical Center and University of Massachusetts Medical School, Worcester, MA, USAView further author information
Pages 289-302 | Received 17 Oct 2016, Accepted 14 Dec 2016, Published online: 10 Jan 2017

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Xun Feng & Yang Chen. (2018) Drug delivery targets and systems for targeted treatment of rheumatoid arthritis. Journal of Drug Targeting 26:10, pages 845-857.
Read now
Dae Hyun Yoo, Jung-Yoon Choe, Seung Cheol Shim & Chang-Hee Suh. (2018) Switching to biosimilars in the treatment of rheumatic diseases. Expert Review of Clinical Immunology 14:7, pages 557-571.
Read now
Dae Hyun Yoo. (2017) CT-P13 in the treatment of rheumatoid arthritis. Expert Review of Clinical Immunology 13:7, pages 653-666.
Read now

Articles from other publishers (10)

Chengbiao Ding, Qi Liu, Wenchong Ouyang, Yichen Sun, Quan Liu, Shuzhan Gao & Zhengwei Wu. (2023) Cold atmospheric pressure plasma: A potential physical therapy for rheumatoid arthritis hyperplastic synovium. International Immunopharmacology 123, pages 110732.
Crossref
S Sajith Kumar, Bhavani Shankara Bagepally & Akhil Sasidharan. (2023) Cost Effectiveness of Rituximab Therapy for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Cost-Utility Studies. Clinical Drug Investigation 43:2, pages 97-108.
Crossref
Mingyo Kim, Yong-ho Choe & Sang-il Lee. (2022) Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research. Immune Network 22:1.
Crossref
David L Scott, Fowzia Ibrahim, Harry Hill, Brian Tom, Louise Prothero, Rhiannon R Baggott, Ailsa Bosworth, James B Galloway, Sofia Georgopoulou, Naomi Martin, Isabel Neatrour, Elena Nikiphorou, Jackie Sturt, Allan Wailoo, Frances MK Williams, Ruth Williams & Heidi Lempp. (2021) Intensive therapy for moderate established rheumatoid arthritis: the TITRATE research programme. Programme Grants for Applied Research 9:8, pages 1-186.
Crossref
Shahin Shams, Joseph M. Martinez, John R. D. Dawson, Juan Flores, Marina Gabriel, Gustavo Garcia, Amanda Guevara, Kaitlin Murray, Noah Pacifici, Maxemiliano V. Vargas, Taylor Voelker, Johannes W. Hell & Judith F. Ashouri. (2021) The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions. Frontiers in Pharmacology 12.
Crossref
Lin-Chau Chang. (2019) The biosimilar pathway in the USA: An analysis of the innovator company and biosimilar company perspectives and beyond. Journal of Food and Drug Analysis 27:3, pages 671-678.
Crossref
Gernot Keyßer & Christoph Schäfer. (2019) Management der rheumatoiden Arthritis. CME 16:3, pages 9-21.
Crossref
Qiang Guo, Yuxiang Wang, Dan Xu, Johannes Nossent, Nathan J. Pavlos & Jiake Xu. (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Research 6:1.
Crossref
Gernot Keyßer & Christoph Schäfer. (2018) Die Rheumatoide ArthritisRheumatoid arthritis. MMW - Fortschritte der Medizin 160:1, pages 50-58.
Crossref
Janet Fricker. (2017) Tackling the Inflammatory Burden of Psoriasis: A Multidisciplinary Approach. European Medical Journal, pages 27-35.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.